Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centre, Randomized, Double-blind, Sham-controlled Study of gammaCore® Non-invasive Vagus Nerve Stimulator (nVNS), for the Acute Treatment of Migraine

NCT02686034 is registered in ClinicalTrials.gov with ElectroCore INC as lead sponsor.

NCT NCT02686034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centre, Randomized, Double-blind, Sham-controlled Study of gammaCore® Non-invasive Vagus Nerve Stimulator (nVNS), for the Acute Treatment of Migraine
Lead sponsor
ElectroCore INC
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
March 31, 2017
Enrollment
285 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

migraine